Pharmaceuticals Current Affairs - 2020

Cabinet Committee on Economic Affairs (CCEA) approved Rs.1750 crore for strengthening the drug regulatory system

The Cabinet Committee on Economic Affairs (CCEA) has approved Rs.1750 crore for strengthening the drug regulatory system both at the Central and the State. The sanctioned amount will be spent for strengthening and up-gradation of the drug regulatory system over a period of three years. The total amount of Rs 1750 crore will be divided Read More…

DRDO developed poly-herbal medicine to treat Leucoderma

Defence Research and Development Organisation (DRDO) has developed a poly-herbal medicine by the trade name of Lukoskin for the treatment of Leucoderma. It was announced by Union Defence Minister Manohar Parrikar in a written reply to Rajya Sabha. The medicine was developed by Haldwani (Uttarakhand) based scientists of Defence Bio-Energy Research (DIBER), which is a Read More…

US FDA hikes fee for generic drug approvals

United state Food and Drugs Administration (USFDA) has hiked its fees by 30 percent for new generic drug applications. Earlier the fee for Abbreviated New Drug Applications (ANDAs) was 58,730 dollars and now has risen by 30 per cent to 76,030 US dollars. This fee is applicable from 1 October 2015. This move will hit Indian Read More…

USFDA approves first anti-epilepsy pill manufactured with 3D printer

Aprecia’s Spritam becomes first anti-epilepsy pill manufactured with 3D printer to get the US Food and Drug Administration (USFDA) approval. The specified porous structure of the pill ‘Spritam’ was developed by using ZipDose 3D printing technology by Aprecia Pharmaceuticals. Designing detail structure of the Spritam pill made it possible for Aprecia to develop a pill that Read More…

Teva to buy Allergan generic drug business for USD 40.5 billion

Israel’s largest drug maker Teva Pharmaceutical agreed to buy generic drugs business of Allergan Plc for USD 40.5 billion. According to the agreement Teva will make cash payment of USD 33.75 billion and USD 6.75 billion of its stock for Allergan. This is the largest acquisition done by any company in Israel’s history. The acquisition will consolidate Teva’s Read More…